Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
boston top stories
inclisiran
life sciences
national blog main
national top stories
5
×
new york blog main
new york top stories
regeneron pharmaceuticals
cholesterol
pcsk9
praluent
repatha
biotech
clinical trials
new york
san francisco blog main
san francisco top stories
sanofi
alirocumab
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
evolocumab
indiana blog main
indiana top stories
ldl
medco
medicines co.
mt sinai hospital
national
pcsk9 inhibitors
prashant vaishnava
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
What
cholesterol
5
×
drug
lowering
medco
medicines
fda
new
twice
wave
abbvie’s
aces
acquire
agreed
announced
barbecuing
big
billion
bio
bringing
brings
camping
cardiologist
cash
center
ceo
check
clears
closer
company
compound
conference
day
deal
drugs
expensive
faces
filing
financial
flexible
flop
Language
unset
Current search:
cholesterol
×
" national top stories "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)